Benzinga - Gainers
- Allarity Therapeutics, Inc. (NASDAQ: ALLR) gained 240% to $0.90. Allarity Therapeutics, last month, posted a Q3 loss of $0.68 per share.
- Maxar Technologies Inc. (NYSE: MAXR) shares jumped 120.2% to $50.86 after the company announced it will be acquired by Advent International for $6.4 billion.
- Trean Insurance Group, Inc. (NASDAQ: TIG) gained 92.2% to $6.00 after the company announced a definitive agreement to be acquired by Altaris Capital Partners for $6.15 per share in cash.
- Dermata Therapeutics, Inc. (NASDAQ: DRMA) jumped 82% to $0.3549. Dermata Therapeutics recently announced topline results from its DMT310 Phase 2 trial, which did not meet primary endpoints.
- BeyondSpring Inc. (NASDAQ: BYSI) gained 39% to $2.1286. BeyondSpring recently presented data with plinabulin for the prevention of docetaxel-induced neutropenia in patients with non-small cell lung cancer and breast cancer at three medical conferences.
- Minim, Inc. (NASDAQ: MINM) shares gained 32.5% to $0.2315 after gaining over 10% on Thursday. Minim, last month, reported worse-than-expected results.
- authID Inc. (NASDAQ: AUID) gained 24.8% to $0.8995.
- Ambrx Biopharma Inc. (NYSE: AMAM) jumped 23.2% to $2.7775.
- Exact Sciences Corporation (NASDAQ: EXAS) shares gained 23.1% to $54.90 after competitor Guardant Health reported results from a study of its colorectal cancer detection blood test.
- Future FinTech Group Inc. (NASDAQ: FTFT) jumped 21.7% to $0.4410
- Nocera, Inc. (NASDAQ: NCRA) gained 20.8% to $1.51.
- Adagene Inc. (NASDAQ: ADAG) jumped 19.8% to $1.5818. Adagene announced clinical trial collaboration to evaluate anti-CTLA-4 SAFEbody ADG126 in combination with Roche's standard-of-care for first-line advanced liver cancer.
- COMSovereign Holding Corp. (NASDAQ: COMS) rose 18.8% to $0.0870.
- Recruiter.com Group, Inc. (NASDAQ: RCRT) jumped 17.4% to $0.44.
- Applied UV, Inc. (NASDAQ: AUVI) gained 17% to $1.12 after the company announced it signed a strategic manufacturing and related services agreement with Canon Virginia.
- Lanvin Group (NASDAQ: LANV) shares gained 17% to $8.93 after dropping over 22% on Thursday.
- Crown ElectroKinetics Corp. (NASDAQ: CRKN) climbed 16.8% to $0.2146 after jumping around 20% on Thursday.
- Gelesis Holdings, Inc. (NYSE: GLS) rose 16.5% to $0.2601.
- United Insurance Holdings Corp. (NASDAQ: UIHC) gained 15.5% to $0.5664.
- TAL Education Group (NYSE: TAL) jumped 15.5% to $7.53.
- Bit Brother Limited (NASDAQ: BTB) rose 14.7% to $7.26 after gaining 24% on Thursday. Bit Brother recently announced a 1-for-15 reverse share split.
- Phio Pharmaceuticals Corp. (NASDAQ: PHIO) gained 13.8% to $0.41. Phio Pharmaceuticals, last month, posted a Q3 loss of $0.26 per share.
- Apollo Medical Holdings, Inc. (NASDAQ: AMEH) surged 12.3% to $30.51. Apollo Medical announced a $50 million share repurchase program.
- Agilysys, Inc. (NASDAQ: AGYS) jumped 11.6% to $78.70. BTIG upgraded Agilysys from Neutral to Buy.
- Scholastic Corporation (NASDAQ: SCHL) gained 10.6% to $38.74 after the company posted Q2 results and raised buyback program to $75 million.
- New Oriental Education & Technology Group Inc. (NYSE: EDU) surged 10.6% to $36.88.
- Arteris, Inc. (NASDAQ: AIP) gained 10.4% to $3.81.
- Sharps Technology, Inc. (NASDAQ: STSS) jumped 10% to $1.32.
- Planet Labs PBC (NYSE: PL) gained 9.4% to $5.39. Planet Labs recently reported better-than-expected financial results and issued strong guidance.
- EUDA Health Holdings Limited (NASDAQ: EUDA) rose 9.1% to $1.80 after gaining around 18% on Thursday.
- Adobe (NASDAQ:ADBE) Inc. (NASDAQ: ADBE) rose 6% to $348.48 after the company reported better-than-expected earnings for its fourth quarter. Adobe said it sees full-year revenue in a range of $19.1 billion to $19.3 billion versus estimates of $19.37 billion. The company expects full-year adjusted earnings to be between $15.15 and $15.45 per share versus estimates of $15.25 per share.
- Synaptogenix, Inc. (NASDAQ: SNPX) shares dipped 72.6% to $1.2950 after the company announced Phase 2 clinical trial of Bryostatin-1 for Advanced Alzheimer's disease. The company said endpoint was not met with statistical significance.
- Avaya Holdings Corp. (NYSE: AVYA) shares fell 62% to $0.1999 following a Wall Street Journal report suggesting the company is nearing a chapter 11 bankruptcy filing.
- Starry Group Holdings, Inc. (NYSE: STRY) dropped 61% to $0.0150. Starry said NYSE has commenced delisting proceedings.
- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) fell 54% to $4.04 after the company priced its 1.6 million unit offering at $5.00 per unit.
- Cosmos Holdings Inc. (NASDAQ: COSM) fell 52.9% to $3.89 following effect of 1:25 reverse stock split.
- Agrify Corporation (NASDAQ: AGFY) shares fell 51% to $0.3999 after the company announced pricing of a public offering.
- Scopus BioPharma Inc. (NASDAQ: SCPS) fell 43% to $0.1930 after climbing around 45% on Thursday.
- NantHealth, Inc. (NASDAQ: NH) dropped 36% to $1.83.
- Guardant Health, Inc. (NASDAQ: GH) dropped 30.9% to $28.50 after the company announced results from its ECLIPSE study evaluating the performance of its blood test for detecting colorectal cancer.
- IMV Inc. (NASDAQ: IMV) fell 27.4% to $2.64 after the company announced a $9 million registered direct offering price at-the-market under Nasdaq rules.
- Faraday Future Intelligent Electric Inc. (NASDAQ: FFIE) fell 26.8% to $0.3514. Faraday Future announced plans to start production of FF 91 Futurist in March 2023 and outlined financing progress and completion of product upgrades.
- 180 Life Sciences Corp. (NASDAQ: ATNF) fell 22.4% to $0.2099. 180 Life Sciences announced a 1-for-20 reverse stock split as part of Nasdaq compliance plan.
- MicroAlgo Inc. (NASDAQ: MLGO) fell 21% to $1.77.
- Camber Energy, Inc. (NYSE: CEI) fell 20.3% to $0.0625. Camber Energy announced one-for-fifty reverse stock split.
- Axcella Health Inc. (NASDAQ: AXLA) dropped 20.2% to $0.3502. SVB Leerink downgraded Axcella Health from Outperform to Market Perform and lowered the price target from $6 to $2.
- Core Scientific, Inc. (NASDAQ: CORZ) fell 19.6% to $0.3457.
- Cemtrex, Inc. (NASDAQ: CETX) dropped 18.2% to $0.1390.
- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) fell 17.6% to $4.49.
- Meiwu Technology Company Limited (NASDAQ: WNW) declined 17.4% to $1.85.
- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) fell 17% to $0.3056.
- MorphoSys AG (NASDAQ: MOR) shares fell 12.8% to $3.48. MorphoSys subsidiary Constellation Pharmaceuticals recently entered into a global licensing agreement with Novartis to research, develop and commercialize its pre-clinical inhibitors of a novel cancer target.
- ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) dipped 12.6% to $7.39.
- MorphoSys AG (NASDAQ: MOR) fell 12.5% to $3.49.
- TG Therapeutics, Inc. (NASDAQ: TGTX) declined 11.8% to $7.59.
- Icosavax, Inc. (NASDAQ: ICVX) fell 11.8% to $8.99.
- SharpLink Gaming Ltd. (NASDAQ: SBET) dropped 11% to $0.3915.
- Novavax, Inc. (NASDAQ: NVAX) fell 10.6% to $10.13. Novavax said it has priced its underwritten public offering to sell 6.5 million shares of its common stock at $10 per share.
- Focus Universal Inc. (NASDAQ: FCUV) fell 10.5% to $7.18.
- Sea Limited (NYSE: SE) fell 9.4% to $55.27.
- Krispy Kreme, Inc. (NASDAQ: DNUT) dropped 8.4% to $12.19. Krispy Kreme reiterated its FY22 financial guidance.
- Coinbase (NASDAQ:COIN) Global, Inc. (NASDAQ: COIN) dropped 6.2% to $35.68.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.